CCB (00939) surged more than 3% in early trading. As of press time, the stock was up 2.99% at HK$7.93, with a turnover of HK$1.17 billion.

Recently, CCB released its Q3 2025 financial report. For the three months ended September 30, 2025, the bank reported revenue of RMB 174.376 billion (down 1.77% YoY) and net profit attributable to shareholders of RMB 95.284 billion (up 4.19% YoY). Basic earnings per share stood at RMB 0.35. As of September 30, 2025, the group's capital adequacy ratio under the Commercial Bank Capital Management Measures was 19.24%, with tier-1 and core tier-1 capital adequacy ratios at 15.19% and 14.36%, respectively. The leverage ratio was 7.64%, while the liquidity coverage ratio for Q3 2025 was 132.40%. All metrics met regulatory requirements.

UBS issued a research note stating that CCB's net profit for the first three quarters of 2025 reached RMB 257.4 billion, up 0.6% YoY, reversing the 1.4% decline seen in the first half. Q3 net profit grew 4.2% YoY, in line with the average of the "Big Four" banks (4.1%). However, the bank's Q3 revenue turned negative, mainly due to a 2.7% YoY drop in net interest income, a 21-basis-point YoY contraction in net interest margin, and weaker non-interest income. UBS expects a slightly negative market reaction to CCB's Q3 results but maintains a "Buy" rating with a target price of HK$10.20.